Development of a Tissue-Equivalent MRI Phantom Using Carrageenan Gel

Koichi Yoshimura, Hirokazu Kato, Masahiro Kuroda, Atsushi Yoshida, Katsumi Hanamoto, Akio Tanaka, Masatoshi Tsunoda, Susumu Kanazawa, Koichi Shibuya, Shoji Kawasaki, Yoshio Hiraki

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

A new tissue-equivalent MRI phantom based on carrageenan gel was developed. Carrageenan gel is an ideal solidifying agent for making large, strong phantoms in a wide variety of shapes. GdCl3 was added as a T 1 modifier and agarose as a T2 modifier. The relaxation times of a very large number of samples were estimated using 1.5-T clinical MRI equipment. The developed phantom was found to have a T1, value of 202-1904 ms and a T2 value of 38-423 ms when the GdCl3 concentration was varied from 0-140 μmol/kg and the agarose concentration was varied from 0-1.6% in a carrageenan concentration that was fixed at 3%. The range of measured relaxation times covered those of all types of human tissue. Empirical formulas linking the relaxation time with the concentration of the modifier were established to enable the accurate and easy calculation of the modifier concentration needed to achieve the required relaxation times. This enables the creation of a phantom having an arbitrary combination of T 1 and T2 values and which is capable of retaining its shape.

Original languageEnglish
Pages (from-to)1011-1017
Number of pages7
JournalMagnetic Resonance in Medicine
Volume50
Issue number5
DOIs
Publication statusPublished - Nov 2003

Fingerprint

Carrageenan
Gels
Sepharose
Equipment and Supplies

Keywords

  • Agarose
  • Carrageenan
  • GdCl
  • MRI phantom

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Development of a Tissue-Equivalent MRI Phantom Using Carrageenan Gel. / Yoshimura, Koichi; Kato, Hirokazu; Kuroda, Masahiro; Yoshida, Atsushi; Hanamoto, Katsumi; Tanaka, Akio; Tsunoda, Masatoshi; Kanazawa, Susumu; Shibuya, Koichi; Kawasaki, Shoji; Hiraki, Yoshio.

In: Magnetic Resonance in Medicine, Vol. 50, No. 5, 11.2003, p. 1011-1017.

Research output: Contribution to journalArticle

Yoshimura, K, Kato, H, Kuroda, M, Yoshida, A, Hanamoto, K, Tanaka, A, Tsunoda, M, Kanazawa, S, Shibuya, K, Kawasaki, S & Hiraki, Y 2003, 'Development of a Tissue-Equivalent MRI Phantom Using Carrageenan Gel', Magnetic Resonance in Medicine, vol. 50, no. 5, pp. 1011-1017. https://doi.org/10.1002/mrm.10619
Yoshimura, Koichi ; Kato, Hirokazu ; Kuroda, Masahiro ; Yoshida, Atsushi ; Hanamoto, Katsumi ; Tanaka, Akio ; Tsunoda, Masatoshi ; Kanazawa, Susumu ; Shibuya, Koichi ; Kawasaki, Shoji ; Hiraki, Yoshio. / Development of a Tissue-Equivalent MRI Phantom Using Carrageenan Gel. In: Magnetic Resonance in Medicine. 2003 ; Vol. 50, No. 5. pp. 1011-1017.
@article{bdb624b10a5f4249afc05a138c01c446,
title = "Development of a Tissue-Equivalent MRI Phantom Using Carrageenan Gel",
abstract = "A new tissue-equivalent MRI phantom based on carrageenan gel was developed. Carrageenan gel is an ideal solidifying agent for making large, strong phantoms in a wide variety of shapes. GdCl3 was added as a T 1 modifier and agarose as a T2 modifier. The relaxation times of a very large number of samples were estimated using 1.5-T clinical MRI equipment. The developed phantom was found to have a T1, value of 202-1904 ms and a T2 value of 38-423 ms when the GdCl3 concentration was varied from 0-140 μmol/kg and the agarose concentration was varied from 0-1.6{\%} in a carrageenan concentration that was fixed at 3{\%}. The range of measured relaxation times covered those of all types of human tissue. Empirical formulas linking the relaxation time with the concentration of the modifier were established to enable the accurate and easy calculation of the modifier concentration needed to achieve the required relaxation times. This enables the creation of a phantom having an arbitrary combination of T 1 and T2 values and which is capable of retaining its shape.",
keywords = "Agarose, Carrageenan, GdCl, MRI phantom",
author = "Koichi Yoshimura and Hirokazu Kato and Masahiro Kuroda and Atsushi Yoshida and Katsumi Hanamoto and Akio Tanaka and Masatoshi Tsunoda and Susumu Kanazawa and Koichi Shibuya and Shoji Kawasaki and Yoshio Hiraki",
year = "2003",
month = "11",
doi = "10.1002/mrm.10619",
language = "English",
volume = "50",
pages = "1011--1017",
journal = "Magnetic Resonance in Medicine",
issn = "0740-3194",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Development of a Tissue-Equivalent MRI Phantom Using Carrageenan Gel

AU - Yoshimura, Koichi

AU - Kato, Hirokazu

AU - Kuroda, Masahiro

AU - Yoshida, Atsushi

AU - Hanamoto, Katsumi

AU - Tanaka, Akio

AU - Tsunoda, Masatoshi

AU - Kanazawa, Susumu

AU - Shibuya, Koichi

AU - Kawasaki, Shoji

AU - Hiraki, Yoshio

PY - 2003/11

Y1 - 2003/11

N2 - A new tissue-equivalent MRI phantom based on carrageenan gel was developed. Carrageenan gel is an ideal solidifying agent for making large, strong phantoms in a wide variety of shapes. GdCl3 was added as a T 1 modifier and agarose as a T2 modifier. The relaxation times of a very large number of samples were estimated using 1.5-T clinical MRI equipment. The developed phantom was found to have a T1, value of 202-1904 ms and a T2 value of 38-423 ms when the GdCl3 concentration was varied from 0-140 μmol/kg and the agarose concentration was varied from 0-1.6% in a carrageenan concentration that was fixed at 3%. The range of measured relaxation times covered those of all types of human tissue. Empirical formulas linking the relaxation time with the concentration of the modifier were established to enable the accurate and easy calculation of the modifier concentration needed to achieve the required relaxation times. This enables the creation of a phantom having an arbitrary combination of T 1 and T2 values and which is capable of retaining its shape.

AB - A new tissue-equivalent MRI phantom based on carrageenan gel was developed. Carrageenan gel is an ideal solidifying agent for making large, strong phantoms in a wide variety of shapes. GdCl3 was added as a T 1 modifier and agarose as a T2 modifier. The relaxation times of a very large number of samples were estimated using 1.5-T clinical MRI equipment. The developed phantom was found to have a T1, value of 202-1904 ms and a T2 value of 38-423 ms when the GdCl3 concentration was varied from 0-140 μmol/kg and the agarose concentration was varied from 0-1.6% in a carrageenan concentration that was fixed at 3%. The range of measured relaxation times covered those of all types of human tissue. Empirical formulas linking the relaxation time with the concentration of the modifier were established to enable the accurate and easy calculation of the modifier concentration needed to achieve the required relaxation times. This enables the creation of a phantom having an arbitrary combination of T 1 and T2 values and which is capable of retaining its shape.

KW - Agarose

KW - Carrageenan

KW - GdCl

KW - MRI phantom

UR - http://www.scopus.com/inward/record.url?scp=10744219941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744219941&partnerID=8YFLogxK

U2 - 10.1002/mrm.10619

DO - 10.1002/mrm.10619

M3 - Article

C2 - 14587012

AN - SCOPUS:10744219941

VL - 50

SP - 1011

EP - 1017

JO - Magnetic Resonance in Medicine

JF - Magnetic Resonance in Medicine

SN - 0740-3194

IS - 5

ER -